Posted in Allergan, GSK, Glaxosmithkline, Merck, Pharma, Pharma News, Pharmaceutical, Schering, tagged botox, Eisai, fosamax, heath ledger, vicriviroc on February 11, 2008 | No Comments »
Lessons from Heath Ledger’s tragic death: Don’t mix prescription drugs.
Merck hands over a cool $649 million to settle allegations about marketing transgressions. Also, launches authorized generic of Fosamax, which lost patent protection this month.
GSK continues slumping due to Avandia decline.
Some Q&A about that recent diabetes study that was halted due to deaths in the (intensive [...]
Read Full Post »
From the WSJ today…
Drug That Lengthens Eyelashes Sets Off Flutter
By RHONDA L. RUNDLE
November 19, 2007; Page B1
In the latest blurring of the line between cosmetics and drugs, new products that promise to make eyelashes look longer are causing a stir among physicians and regulators because they contain ingredients that are the same or similar to those in [...]
Read Full Post »
Posted in Allergan, Bayer, Celgene, Genzyme, News, Novartis, Oncology, Pfizer, Pharma, Pharma News, Pharmaceutical, Takeda on September 21, 2007 | 1 Comment »
A summary of the belt-tightening state of Big Pharma right now, from Med Ad News.
From ABC, Ten Health Advances that have changed the world.
Americans trust the FDA more than pharma companies.
Pfizer’s new anti-smoking pill (Chantix) taking off.
Bayer and Genzyme get expanded labelling for oncology drug Campath.
Celgene reports great financial results due to sales of blood [...]
Read Full Post »
